Synopsis of recent research by authors named "Xing-Yu Xu"
- Xing-Yu Xu's recent research primarily focuses on the modulation of inflammatory processes and disease mechanisms, particularly in neurological conditions, as evidenced by their study on the BET inhibitor ABBV-744, which alleviates LPS-induced neuroinflammation through specific molecular pathways.
- The author has also explored the role of microRNAs, specifically miR-199a-5p, in choroidal neovascularization, highlighting its regulatory effect on the Wnt7b/Wnt/β-catenin signaling pathway, which is crucial in various ocular diseases.
- Additionally, Xu's work includes the development of a sensitive fluorescent probe for detecting Erythromycin in water, emphasizing innovative approaches to environmental monitoring and health safety concerning pharmaceuticals.